tiprankstipranks
Advertisement
Advertisement

SPRC Stock Latest News

SciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
Company AnnouncementsSciSparc Subsidiary Wins Conditional TSXV Nod for CliniQuantum Acquisition, Amends Deal Terms
1d ago
6K
SPRC
SciSparc Regains Conditional Nasdaq Compliance After Equity Shortfall
PremiumCompany Announcements
SciSparc Regains Conditional Nasdaq Compliance After Equity Shortfall
19d ago
6K
SPRC
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
PremiumThe Fly
Psychedelic: AtaiBeckley reports publication of BPL-003 study results
2M ago
ATAI
CMND
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing
PremiumCompany Announcements
SciSparc’s NeuroThera-Backed Collaboration Spurs New Depression Therapy Patent Filing
2M ago
6K
SPRC
SciSparc discloses patent application for depression yherapy
PremiumThe Fly
SciSparc discloses patent application for depression yherapy
3M ago
SPRC
Clearmind Medicine announces Hong Kong patent filing for depression therapy
PremiumThe FlyClearmind Medicine announces Hong Kong patent filing for depression therapy
3M ago
CMND
SPRC
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
Premium
Company Announcements
SciSparc Subsidiary NeuroThera to Take Majority Stake in Quantum Trials Firm CliniQuantum
3M ago
6K
SPRC
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
Premium
The Fly
Psychedelic: Clearmind advances recruitment for CMND-100 trial’s third cohort
3M ago
ATAI
CMND
SciSparc’s Neurothera Labs announces publication of international patent
PremiumThe Fly
SciSparc’s Neurothera Labs announces publication of international patent
3M ago
CMND
SPRC
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum
PremiumThe Fly
SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum
3M ago
SPRC
Scisparc Ltd trading halted, news pending
PremiumThe Fly
Scisparc Ltd trading halted, news pending
3M ago
SPRC
SciSparc announces 1-for-9 reverse share split
PremiumThe Fly
SciSparc announces 1-for-9 reverse share split
3M ago
SPRC
SciSparc announces 1-for-9 reverse share split
PremiumThe FlySciSparc announces 1-for-9 reverse share split
3M ago
SPRC
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
Premium
Company Announcements
SciSparc to Enact 1-for-9 Reverse Share Split as Outstanding Shares Shrink
3M ago
6K
SPRC
SciSparc announces 1-for-9 reverse share split
Premium
The Fly
SciSparc announces 1-for-9 reverse share split
3M ago
SPRC
SciSparc files to sell 23.04M ordinary shares for holders
PremiumThe Fly
SciSparc files to sell 23.04M ordinary shares for holders
3M ago
SPRC
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note
PremiumCompany Announcements
SciSparc Amends $10 Million Note Deal, Issues $2 Million Initial Convertible Note
3M ago
6K
SPRC
SciSparc Sets Up $10 Million Convertible Note Facility With Warrants
PremiumCompany Announcements
SciSparc Sets Up $10 Million Convertible Note Facility With Warrants
4M ago
6K
SPRC
SciSparc Shareholders Approve February Governance Agenda
PremiumCompany Announcements
SciSparc Shareholders Approve February Governance Agenda
4M ago
6K
SPRC
SciSparc files $50M mixed securities shelf
PremiumThe FlySciSparc files $50M mixed securities shelf
4M ago
SPRC
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform
Premium
Company Announcements
SciSparc Subsidiary NeuroThera Wins U.S. Patent for Cannabinoid-Based Antimicrobial Resistance Platform
4M ago
6K
SPRC
SciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech
Premium
The Fly
SciSparc says Neurothera Labs granted U.S. patent for cannabinoid tech
4M ago
SPRC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >